Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Furlong

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Research Involvement and Engagement|January 3, 2024
Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trialsPatricia Furlong, Ashish Dugar, Molly White
Frontiers in Medicine|February 21, 2025
A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapiesLucie Perillat, Andrew McFadyen, Patricia Furlong, et al.
The American Journal of Bioethics : AJOB|October 19, 2021
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?Holly Fernandez Lynch, Arthur Caplan, Patricia Furlong, et al.
The Patient|March 4, 2022
A Comparison of Caregiver and Patient Preferences for Treating Duchenne Muscular DystrophyNorah L Crossnohere, Ryan Fischer, Elizabeth Vroom, et al.
BMJ Innovations|September 12, 2017
Defining patient centricity with patients for patients and caregivers: a collaborative endeavourGuy Yeoman, Patricia Furlong, Michael Seres, et al.
Therapeutic Innovation & Regulatory Science|March 24, 2022
Unmet Therapeutic Needs of Non-Ambulatory Patients with Duchenne Muscular Dystrophy: A Mixed-Method AnalysisAnne L R Schuster, Norah L Crossnohere, Ryan Fischer, et al.
Cytometry. Part B, Clinical Cytometry|August 30, 2008
Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancerDavid Goodale, Carolina Phay, Wendy Brown, et al.
Journal of Medical Internet Research|December 3, 2024
Patients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative StudyLisa McCann, Liane Lewis, Olubukola Oduntan, et al.
Journal of Participatory Medicine|July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine|March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Research Involvement and Engagement|January 3, 2024
Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trialsPatricia Furlong, Ashish Dugar, Molly White
Frontiers in Medicine|February 21, 2025
A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapiesLucie Perillat, Andrew McFadyen, Patricia Furlong, et al.
The American Journal of Bioethics : AJOB|October 19, 2021
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?Holly Fernandez Lynch, Arthur Caplan, Patricia Furlong, et al.
The Patient|March 4, 2022
A Comparison of Caregiver and Patient Preferences for Treating Duchenne Muscular DystrophyNorah L Crossnohere, Ryan Fischer, Elizabeth Vroom, et al.
BMJ Innovations|September 12, 2017
Defining patient centricity with patients for patients and caregivers: a collaborative endeavourGuy Yeoman, Patricia Furlong, Michael Seres, et al.
Therapeutic Innovation & Regulatory Science|March 24, 2022
Unmet Therapeutic Needs of Non-Ambulatory Patients with Duchenne Muscular Dystrophy: A Mixed-Method AnalysisAnne L R Schuster, Norah L Crossnohere, Ryan Fischer, et al.
Cytometry. Part B, Clinical Cytometry|August 30, 2008
Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancerDavid Goodale, Carolina Phay, Wendy Brown, et al.
Journal of Medical Internet Research|December 3, 2024
Patients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative StudyLisa McCann, Liane Lewis, Olubukola Oduntan, et al.
Journal of Participatory Medicine|July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine|March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical TrialsTimothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Pageof 1